Module 3: Neurotoxicology
Recorded On: 12/23/2025
This introductory lecture will cover the topics of neurotoxicology and neurodevelopment. After a brief discussion of the regulatory guidelines and guidance documents that govern neurotoxicology studies, the focus of the lecture will be on describing functional and structural assessments used to characterize alterations in nervous system structure and function. Several types of functional tests will be discussed in the context of neurobiology, regulatory requirements, the advantages and disadvantages of each test, and the species that can be tested in each assessment, using positive control data for illustration, where available. This section of the lecture will end with a discussion of generic factors that can influence neurobehavior data. The second half of the lecture will focus on structural assessments of the brain, and the central and peripheral nervous systems. Options available for neurohistopathology, immunohistochemistry, and brain morphometry will be discussed. The discussion will again focus on the advantages and disadvantages of each stain, with illustrative micrographs. At the end, general concepts of adult versus developmental (juvenile) neurotoxicity will be introduced, followed by the final few slides focused on data interpretation, the relationship between functional and structural deficits, and the importance of using the weight-of-the-evidence approach to draw conclusions regarding treatment-relatedness and adversity.
Pragati Coder, PhD, DABT
Global Scientific Lead for Developmental and Reproductive Toxicology
Charles River Laboratories
Dr. Pragati Coder is a Global Scientific Lead for Developmental and Reproductive Toxicology (DART; C&C) at Charles River Laboratories. She also serves as the Senior Director and Scientific Lead for DART, Juvenile and Neurotoxicology for Charles River’s site in Ashland, Ohio. She received her doctorate in molecular biology from the Indian Institute of Technology-Bombay, India, and was a postdoctoral fellow in reproductive toxicology at the College of Pharmacy, The University of Texas at Austin. Dr. Coder is board-certified as a Diplomate of the American Board of Toxicology and serves as a subject matter expert for developmental, reproductive, endocrine, neurotoxicity, and juvenile toxicity studies that support product development programs for pharmaceutical, (agro) chemical, and veterinary medical products.
She is an active member of the international DART scientific community and several professional organizations, including the Society of Toxicology, Society for Birth Defects Research and Prevention, Health and Environmental Science Institute (HESI-DART), European Teratology Society, and the Middle Atlantic Reproduction and Teratology Association (MARTA) where she has served in various official capacities. She is currently the President of the Society for Birth Defects Research and Prevention.